dihydroergotamine has been researched along with ergoline in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (78.57) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barthel, W; Frosch, G; Glusa, E | 1 |
| Arcari, G; Bernardi, L; Bosisio, G; Croci, M; Elli, C; Falconi, G; Glaesser, A; Temperilli, A | 1 |
| Loeffler, LJ; Schran, HF; Schwarz, HJ; Talbot, KC | 1 |
| Nasr, H; Pearson, OH | 1 |
| Brown, AM; Kaumann, AJ; Patch, TL | 1 |
| Egou, H; Itakura, T; Matsumoto, M; Matsuoka, Y; Shintomi, K; Tanaka, T; Yoshimoto, K | 1 |
| Narita, H; Ogawa, Y; Shintomi, K; Yoshimoto, K | 1 |
| Fukushima, T; Itakura, T; Matsuoka, Y; Ogawa, Y; Shintomi, K; Yoshimoto, K | 1 |
| Vajnorský, J | 1 |
| Kugler, JE; Meurer-Krüll, BC | 1 |
| Kanto, J | 1 |
| Beleslin, D; Samardzić, R | 1 |
| Delaforge, M; Mansuy, D; Peyronneau, MA; Renaud, JP; Riviere, R | 1 |
| Havemann, J; Keller, U; Loll, B; Vogel, D | 1 |
1 review(s) available for dihydroergotamine and ergoline
| Article | Year |
|---|---|
Clinical pharmacokinetics of ergotamine, dihydroergotamine, ergotoxine, bromocriptine, methysergide, and lergotrile.
Topics: Absorption; Animals; Bromocriptine; Dihydroergotamine; Ergolines; Ergot Alkaloids; Ergotamine; Half-Life; Humans; Kinetics; Methysergide | 1983 |
1 trial(s) available for dihydroergotamine and ergoline
| Article | Year |
|---|---|
[Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
Topics: Aged; Amnesia; Cerebrovascular Disorders; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Electroencephalography; Ergolines; Female; Humans; Male; Middle Aged; Nicergoline; Psychometrics; Psychomotor Performance; Random Allocation | 1985 |
12 other study(ies) available for dihydroergotamine and ergoline
| Article | Year |
|---|---|
[Effect of ergoline derivatives on platelet and blood vessels].
Topics: Adrenergic alpha-Antagonists; Animals; Blood Volume; Dihydroergotamine; Epinephrine; Ergolines; Humans; Norepinephrine; Platelet Aggregation; Rabbits; Thrombosis; Vasoconstriction | 1979 |
Ergoline derivatives with oral, prolonged, alpha-adrenolytic activity.
Topics: Administration, Oral; Animals; Delayed-Action Preparations; Dihydroergotamine; Ergolines; Guinea Pigs; Injections, Intravenous; Male; Nicergoline; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Sympatholytics | 1978 |
Specific radioimmunoassay of ergot peptide alkaloids in plasma.
Topics: Bromocriptine; Cross Reactions; Dihydroergotamine; Ergolines; Ergotamine; Humans; Radioimmunoassay; Structure-Activity Relationship | 1979 |
Inhibition of prolactin secretion by ergot alkaloids.
Topics: Animals; Depression, Chemical; Dihydroergotamine; Dihydroergotoxine; Ergolines; Ergot Alkaloids; Ergotamine; Estradiol; Estrus; Female; Mammary Neoplasms, Experimental; Perphenazine; Pituitary Gland; Pregnancy; Prolactin; Rats | 1975 |
The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus.
Topics: Animals; Binding, Competitive; Choroid Plexus; Dihydroergotamine; Ergolines; Ergotamine; In Vitro Techniques; Inositol Phosphates; Migraine Disorders; Piperazines; Receptors, Serotonin; Serotonin; Swine; Thermodynamics | 1991 |
[Pharmacological study of nicergoline. (I): Protective effect against anoxic brain damages in animals].
Topics: Animals; Brain; Dihydroergotamine; Electroencephalography; Electron Transport Complex IV; Epinephrine; Ergolines; Hypoxia, Brain; Male; Mice; Mice, Inbred Strains; Nicergoline; Phentolamine; Rats; Rats, Inbred Strains | 1986 |
[Pharmacological study of nicergoline. (III). Effects on cerebral and peripheral circulation in animals].
Topics: Animals; Blood Circulation; Brain; Cats; Dihydroergotamine; Epinephrine; Ergolines; Female; Hemodynamics; Male; Nicergoline; Norepinephrine; Papaverine; Rats; Rats, Inbred SHR; Regional Blood Flow; Vasodilator Agents | 1986 |
[Pharmacological study of nicergoline. (II). Protective effect on ischemic brain damages in animals].
Topics: Animals; Brain; Brain Ischemia; Dihydroergotamine; Energy Metabolism; Ergolines; Female; Gerbillinae; Lipid Peroxides; Male; Mice; Mice, Inbred ICR; Nicergoline; Rats; Rats, Inbred Strains; Seizures | 1986 |
[Treatment of migraine attacks in children with dihydroergotamine Spofa and lysenyl].
Topics: Adolescent; Child; Dihydroergotamine; Electroencephalography; Ergolines; Female; Humans; Lisuride; Male; Migraine Disorders | 1986 |
[Effect of nicergoline and dihydroergotamine, injected into the cerebral ventricles, on arterial pressure in the cat].
Topics: Animals; Blood Pressure; Cats; Cerebral Ventricles; Dihydroergotamine; Dose-Response Relationship, Drug; Ergolines; Female; Injections, Intraventricular; Male; Nicergoline | 1982 |
High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine.
Topics: Animals; Bromocriptine; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dexamethasone; Dihydroergotamine; Ergolines; Humans; Hydroxylation; Isoenzymes; Lysergic Acid; Microsomes, Liver; Mixed Function Oxygenases; NADP; Oxidation-Reduction; Peptides; Rats; Recombinant Proteins; Saccharomyces cerevisiae; Substrate Specificity | 1994 |
Cyclolization of D-lysergic acid alkaloid peptides.
Topics: Biocatalysis; Claviceps; Cyclization; Dihydroergotamine; Dioxygenases; Ergolines; Ergotamine; Humans; Hydroxylation; Lysergic Acid; Mixed Function Oxygenases; Models, Molecular; Peptide Synthases; Peptides; Protein Conformation | 2014 |